Next Article in Journal
In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations
Next Article in Special Issue
Microencapsulation of Salmonella-Specific Bacteriophage Felix O1 Using Spray-Drying in a pH-Responsive Formulation and Direct Compression Tableting of Powders into a Solid Oral Dosage Form
Previous Article in Journal
Chemical Characterization, Antioxidant, Cytotoxic and Microbiological Activities of the Essential Oil of Leaf of Tithonia Diversifolia (Hemsl) A. Gray (Asteraceae)
Previous Article in Special Issue
Parallel Evolution of Host-Attachment Proteins in Phage PP01 Populations Adapting to Escherichia coli O157:H7
Review

Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth

Department of Biology/Toxicology, Ashland University, 401 College Ave., Ashland, OH 44805, USA
Pharmaceuticals 2019, 12(1), 35; https://0-doi-org.brum.beds.ac.uk/10.3390/ph12010035
Received: 28 December 2018 / Revised: 20 February 2019 / Accepted: 4 March 2019 / Published: 11 March 2019
(This article belongs to the Special Issue Phage Therapy and Phage-Mediated Biological Control)
For a bacteriophage to be useful for phage therapy it must be both isolated from the environment and shown to have certain characteristics beyond just killing strains of the target bacterial pathogen. These include desirable characteristics such as a relatively broad host range and a lack of other characteristics such as carrying toxin genes and the ability to form a lysogen. While phages are commonly isolated first and subsequently characterized, it is possible to alter isolation procedures to bias the isolation toward phages with desirable characteristics. Some of these variations are regularly used by some groups while others have only been shown in a few publications. In this review I will describe (1) isolation procedures and variations that are designed to isolate phages with broader host ranges, (2) characterization procedures used to show that a phage may have utility in phage therapy, including some of the limits of such characterization, and (3) results of a survey and discussion with phage researchers in industry and academia on the practice of characterization of phages. View Full-Text
Keywords: phage therapy; bacteriophage isolation; host range; bacteriophage characterization; genome sequencing; enrichment culture phage therapy; bacteriophage isolation; host range; bacteriophage characterization; genome sequencing; enrichment culture
Show Figures

Figure 1

MDPI and ACS Style

Hyman, P. Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth. Pharmaceuticals 2019, 12, 35. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12010035

AMA Style

Hyman P. Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth. Pharmaceuticals. 2019; 12(1):35. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12010035

Chicago/Turabian Style

Hyman, Paul. 2019. "Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth" Pharmaceuticals 12, no. 1: 35. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12010035

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop